S&CO Inc. Buys 6,000 Shares of Enovix Co. (NASDAQ:ENVX)

S&CO Inc. increased its stake in shares of Enovix Co. (NASDAQ:ENVXFree Report) by 42.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,000 shares of the company’s stock after acquiring an additional 6,000 shares during the quarter. S&CO Inc.’s holdings in Enovix were worth $186,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ENVX. Swiss National Bank raised its position in Enovix by 5.0% in the first quarter. Swiss National Bank now owns 281,600 shares of the company’s stock worth $2,256,000 after acquiring an additional 13,400 shares during the period. Avantax Advisory Services Inc. grew its stake in Enovix by 14.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 26,187 shares of the company’s stock worth $210,000 after buying an additional 3,384 shares in the last quarter. ProShare Advisors LLC boosted its stake in shares of Enovix by 8.5% in the 1st quarter. ProShare Advisors LLC now owns 24,915 shares of the company’s stock valued at $200,000 after purchasing an additional 1,960 shares in the last quarter. Blair William & Co. IL purchased a new stake in shares of Enovix in the 1st quarter valued at $268,000. Finally, Nwam LLC purchased a new stake in shares of Enovix in the 1st quarter valued at $93,000. 50.92% of the stock is owned by institutional investors.

Insider Buying and Selling at Enovix

In other news, insider Arthi Chakravarthy sold 35,000 shares of the stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $13.00, for a total value of $455,000.00. Following the completion of the sale, the insider now owns 343,305 shares in the company, valued at approximately $4,462,965. This trade represents a 9.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 15.70% of the stock is owned by corporate insiders.

Enovix Trading Down 4.2 %

Shares of ENVX opened at $8.48 on Friday. The stock has a 50-day simple moving average of $9.98 and a 200-day simple moving average of $11.29. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. Enovix Co. has a 1 year low of $5.70 and a 1 year high of $18.68.

Enovix (NASDAQ:ENVXGet Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.20) by $0.03. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. The company had revenue of $4.30 million for the quarter, compared to analyst estimates of $4.11 million. During the same quarter in the previous year, the company posted ($0.27) earnings per share. As a group, equities analysts forecast that Enovix Co. will post -1.17 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Benchmark reiterated a “buy” rating and set a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. Janney Montgomery Scott lowered shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research note on Thursday, October 31st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 price target on shares of Enovix in a research note on Wednesday, October 30th. JPMorgan Chase & Co. cut their price objective on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price target (down previously from $23.00) on shares of Enovix in a report on Monday, August 5th. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Enovix presently has an average rating of “Moderate Buy” and an average target price of $20.50.

Check Out Our Latest Research Report on ENVX

Enovix Company Profile

(Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Recommended Stories

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVXFree Report).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.